Alectinib Induced SJS/TEN: A Case Report and a Review
Lung cancer is the second most common type of cancer in the world, adenocarcinoma is one of the most common variants with a rate of 35-40%.[1] Recent years, in NSCLC with relation to genetic alterations, biomolecular markers have emerged as a cornerstone of the advanced NSCLC treatment that overtook...
Saved in:
Published in | Türk onkoloji dergisi Vol. 39; no. 1; pp. 129 - 134 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Istanbul
Kare Publishing
2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!